Evangelos G. Papanikolaou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Evangelos G. Papanikolaou has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
H. Tournaye
4 shared publicationsP. Devroey
4 shared publicationsH. Fatemi
3 shared publicationsA. Zavos
2 shared publicationsB. Tarlatzis
2 shared publicationsB.C. Tarlatzis
2 shared publications
Latest Publications
- 1 September 2013
- Published by Elsevier in Fertility and Sterility
- Vol. 100 (3) , S469
Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. a proof of concept study
- 1 September 2013
- Published by Elsevier in Fertility and Sterility
- Vol. 100 (3) , S469
Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. a proof of concept study
- 1 December 2011
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 31 (4) , 217-218
Obstetric Outcomes After Treatment of Periodontal Disease During Pregnancy
- 1 December 2011
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 31 (4) , 217-218
Obstetric Outcomes After Treatment of Periodontal Disease During Pregnancy
- Open Access
- 1 January 2011
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 26 (Supplement)
SELECTED ORAL COMMUNICATION SESSION, SESSION 44: SURGERY, Tuesday 5 July 2011 15:15 - 16:30
Introduction: Infertility affects 10% of the population of fertile age. Improvements in reproductive medicine have overcome most causes of infertility, with the exception of uterine factor infertility, due either to absence of a uterus (congenital or acquired) or presence of a non-functional uterus. No population-based study has been done to accurately determine the size of this group of women but in the UK it has been suggested to include 12,000–15,000 women. Uterus transplantation (UTx) may become a treatment for this large group of permanently infertile women.
- 1 January 2011
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 26 (Supplement)
Open AccessSELECTED ORAL COMMUNICATION SESSION, SESSION 44: SURGERY, Tuesday 5 July 2011 15:15 - 16:30
Introduction: Infertility affects 10% of the population of fertile age. Improvements in reproductive medicine have overcome most causes of infertility, with the exception of uterine factor infertility, due either to absence of a uterus (congenital or acquired) or presence of a non-functional uterus. No population-based study has been done to accurately determine the size of this group of women but in the UK it has been suggested to include 12,000–15,000 women. Uterus transplantation (UTx) may become a treatment for this large group of permanently infertile women.
- 1 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (7) , 2902-2904
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial
- 1 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (7) , 2902-2904
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial
- 16 November 2010
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 28 (06) , 458-462
Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS), an iatrogenic complication of ovarian stimulation for assisted reproduction, is a potentially life-threatening condition. Exogenous human chorionic gonadotropin (hCG) administered for final oocyte maturation and endogenous hCG produced by a developing pregnancy are fundamental in the development of the disease. Vascular endothelial growth factor is the key molecule mediating the pathophysiology of the syndrome, and genetic predisposition might play a role. Because the most severe cases are usually the late OHSS cases that occur when a pregnancy is established, several predictive markers have been introduced to identify the high-risk patient profile and consequently develop preventive strategies. This article reviews the most recent evidence evaluating the accuracy of different OHSS prediction parameters. Stratification was attempted according to the phase of the ovarian stimulation that the patients undergo. Anti-Müllerian hormone and the number of follicles seen on ultrasound seem promising discriminating factors, whereas prediction models that include age, antral follicle count, and estrogen levels on the day of ovulation triggering provide variable sensitivity and specificity. Until reliable genetic tests are available, and considering that the occurrence of pregnancy is unpredictable, the use of prognostic factors will be mainly indicative of risk rather than preventive of OHSS.
- 16 November 2010
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 28 (06) , 458-462
Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS), an iatrogenic complication of ovarian stimulation for assisted reproduction, is a potentially life-threatening condition. Exogenous human chorionic gonadotropin (hCG) administered for final oocyte maturation and endogenous hCG produced by a developing pregnancy are fundamental in the development of the disease. Vascular endothelial growth factor is the key molecule mediating the pathophysiology of the syndrome, and genetic predisposition might play a role. Because the most severe cases are usually the late OHSS cases that occur when a pregnancy is established, several predictive markers have been introduced to identify the high-risk patient profile and consequently develop preventive strategies. This article reviews the most recent evidence evaluating the accuracy of different OHSS prediction parameters. Stratification was attempted according to the phase of the ovarian stimulation that the patients undergo. Anti-Müllerian hormone and the number of follicles seen on ultrasound seem promising discriminating factors, whereas prediction models that include age, antral follicle count, and estrogen levels on the day of ovulation triggering provide variable sensitivity and specificity. Until reliable genetic tests are available, and considering that the occurrence of pregnancy is unpredictable, the use of prognostic factors will be mainly indicative of risk rather than preventive of OHSS.
- 1 July 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 21 (1) , 50-55
Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study
- 1 July 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 21 (1) , 50-55
Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study
- 30 September 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90, S349
Increased clinical pregnancy rates by using hyaluronan in in-vitro fertilization: a systematic review and meta-analysis
- 30 September 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90, S349
Increased clinical pregnancy rates by using hyaluronan in in-vitro fertilization: a systematic review and meta-analysis
- 30 September 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90, S358
Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and meta-analysis
- 30 September 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90, S358
Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and meta-analysis
- 30 September 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 88, S112
GnRH-agonist vs. GnRH-antagonist in elective single blastocyst transfer IVF cycles
- 30 September 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 88, S112
GnRH-agonist vs. GnRH-antagonist in elective single blastocyst transfer IVF cycles
- 30 September 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 88, S317-317
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. a systematic review and meta-analysis
- 30 September 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 88, S317-317
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. a systematic review and meta-analysis